Advertisement

Ads Placeholder
Loading...

argenx SE

ARGXNASDAQ
Healthcare
Biotechnology
$746.42
$3.30(0.44%)
U.S. Market opens in 32h 12m

argenx SE (ARGX) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap46.2B
P/E Ratio21.27
EPS (TTM)$19.54
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$695.48
3 Months$774.20
1 Year Target$821.95

ARGX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of A, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 55.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $821.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.27 and a market capitalization of 46.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.44%
5-Day Change
7.26%
1-Month Change
-0.31%
3-Month Change
-11.14%
6-Month Change
-6.70%
Year-to-Date (YTD) Change
-11.14%
1-Year Change
26.50%
3-Year Change
107.26%
5-Year Change
158.86%
All-Time (Max) Change
3145.30%

Contact Information

31 10 703 8441
Laarderhoogtweg 25, Amsterdam, NaN, 1101EB

Company Facts

15,990 Employees
IPO DateMay 18, 2017
CountryNL
Actively Trading

Frequently Asked Questions